期刊文献+

进展期胃癌腹主动脉旁淋巴结转移的相关因素及其对预后的影响 被引量:6

Influencing factors and prognostic impact of para-aortic lymph nodes metastasis in advanced gastric cancer
下载PDF
导出
摘要 目的分析进展期胃癌腹主动脉旁淋巴结(No.16组淋巴结)转移的相关临床病理因素及其对预后的影响。方法接受根治性腹主动脉旁淋巴结清扫的进展期胃癌95例,依No.16组淋巴结转移状况分为阴性组(n=64)、阳性组(n=31),分析No.16组淋巴结转移的相关临床病理因素及其对预后影响。结果 Logistic回归分析表明,性别、年龄、肿瘤部位、大小、远处转移率、Borrmann分型、WHO分型、分化程度、CEA与No.16组淋巴结转移无显著相关性(均P>0.05)。No.16阳性组与阴性组中,累及邻近脏器(T4)者分别占54.8%、32.8%,淋巴结转移度>40%者分别占74.2%、14.1%,TNMⅣ期者分别占83.9%、43.8%,肿瘤临近脏器浸润(T4)、临床分期Ⅳ期、淋巴结转移度>40%与No.16组淋巴结转移相关。No.16组淋巴结转移阴性和阳性患者的中位生存期分别为45.5、9.7个月,阳性组预后显著不良(P<0.05)。生存分析显示肿瘤部位、分化程度、淋巴结转移度、远处转移、No.16组淋巴结转移、TNM分期影响患者预后。COX回归分析显示No.16组淋巴结转移、分化程度为独立预后因素。分层分析表明,无脏器侵犯、合并脏器侵犯、淋巴结转移度1%~40%、无远处转移时,No.16阳性组的预后均显著不良(均P<0.05)。淋巴结转移度41%~100%、合并远处转移时,两组的预后相比,差异无统计学意义(P>0.05)。No.16组淋巴结阳性、远处转移、No.16组淋巴结并远处转移患者之间的预后比较差异无统计学意义(P>0.05)。结论对接受根治性No.16组淋巴结清扫的胃癌患者,邻近脏器浸润、淋巴结转移度>40%为No.16组淋巴结转移的主要相关因素,No.16组淋巴结转移患者的预后与远处转移者相当。 Objective To analyze the influencing factors and prognostic impact of para-aortic lymph nodes metastasis (PALN) in gastric cancer. Methods From January 1997 to January 2010 , 95 cases with advanced gastric cancer underwent D2 or D2+ radical resection plus PALN dissection in Gastric Cancer Center of Sun Yat-sen University. All cases were divided into No.16 positive group (n=31) and negative group (n=64). The influencing factors of PALN metastasis were analyzed , and prognosis of the two groups was compared. Results Gender, age, tumor location, tumor size, distal metastasis, Borrmann type, WHO type, differentiation degree , and CEA value were not correlated with PALN metastasis (P>0.05). The percentages of the patients with T 4 invasion, lymph node metastasis ratio more than 40% , TNM Ⅳ stage, in PALN positive and negative groups were respectively 54.8% and 32.8% , 74.2% and 14.1%, 83.9% and 43.8% (all P<0.05). Multivariate analysis showed the major influencing factors of PALN metastasis included adjacent organs invasion (P =0.033) and lymph nodes metastasis ratio more than 40% (P=0.000). The median survival time of the No.16 positive and negative groups were 45.5 and 9.7 months (P <0.05). Survival analysis revealed that tumor location , differentiationdegree, lymph node metastasis ratio , distant metastasis, PALN metastasis, TNM stage were significantly associated with prognosis ,while only PALN metastasis and differentiation degree were independent prognostic factors. There were no significant differences in survival among the patients with PALN or distant metastasis and both of them. Conclusions In advanced gastric cancer, adjacent organ invasion and LN metastasis ratio more than 40% were the major influencing factors of PALN metastasis. PALN metastasis and differentiation degree are independent prognostic factors. The prognosis in cases with positive PALN was similar to that with distal metastasis.
出处 《消化肿瘤杂志(电子版)》 2012年第2期82-88,共7页 Journal of Digestive Oncology(Electronic Version)
关键词 胃癌 腹主动脉旁淋巴结转移 外科手术 临床病理 预后 Stomach neoplasms Para-aortic lymph node metastasis Surgery Clinicopathology Prognosis
  • 相关文献

参考文献16

  • 1Sasako M,Sano T,Yamanoto S. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer[J].New England Journal of Medicine,2008,(05):453-462.
  • 2詹文华,何裕隆,郑章清,彭俊生,蔡世荣,马晋平.进展期胃癌行腹主动脉旁淋巴结清扫的疗效观察[J].中华外科杂志,2003,41(5):375-378. 被引量:37
  • 3Tokunaga M,Ojyama S,Hiki N. Can super extended lymph node dissection be justified for gastric cancer with pathologically positive para-aortic lymph nodes[J].Annals of Surgical Oncology,2010,(08):2031-2036.
  • 4詹文华,韩方海,何裕隆,李玉明,彭俊生,蔡世荣,马晋平.进展期胃癌腹主动脉旁淋巴结转移规律及其清扫对临床结局的影响[J].中华胃肠外科杂志,2006,9(1):17-22. 被引量:41
  • 5Giovanni,Alberto,Franco. Tumor site and perigastric nodal status are the most important predictors of para-aortic nodal involvement in advanced gastric cancer[J].Annals of Surgical Oncology,2011,(08):2273-2280.
  • 6Daniele,Maria,Corrado. High Accuracy of Multislices Computed Tomography (MSCT) for para-aortic lymph node metastases from gastric cancer:a prospective single-center study[J].Annals of Surgical Oncology,2011,(08):2265-2272.
  • 7车向明,夏越祥次,爱甲孝.进展期胃癌腹主动脉旁淋巴结微小转移与患者预后的关系[J].中华外科杂志,2004,42(7):421-423. 被引量:8
  • 8Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver.3)[J].Gastric Cancer:Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,2011,(02):113-123.
  • 9吴迪,张昊,刘彩刚,路平.胃癌腹主动脉旁淋巴结转移的危险因素——一项基于二十年住院患者的研究结果(英文)[J].肿瘤防治研究,2010,37(11):1273-1276. 被引量:1
  • 10Alberto,Daniele,Franco. Lymph node involvement in gastric cancer for different tumor sites and T stage Italian Research Group for Gastric Cancer (IRGGC) Experience[J].Journal of Gastrointestinal Surgery,2007,(09):1146-1153.

二级参考文献41

  • 1刘统成,郑章清,何裕隆,马晋平,郑朝旭,詹文华.根治性淋巴结清扫治疗早期胃癌的价值——附19例临床分析[J].中国胃肠外科杂志,1999,2(4):220-222. 被引量:3
  • 2Parkin DM.Epidemiology of cancer global patterns and trends.Toxicol Lett,1998,28:102-103,227-234.
  • 3Howson CP,Hiyama T,Wynder EL.The decline in gastric cancer epidemiology of an unplanned triumph.Epidemiol Rev,1986,8:1-27.
  • 4Hartgrink HH,Velde CJH,Putter H,et al.Extended lymph node dissection fro gastric cancer:who may benefit? Final results of the randomized Dutch Gastric Cancer Group Trial.J Clin Oncol,2004,22:2069-2077.
  • 5太田惠一郎,大山繁和,高桥孝,他.胃癌手術の歷史的變遷.消化器外科,1997,22:1175-1184.
  • 6伊藤雅史,平山廉三,前岛静顯,他.解剖学的見地ょりみた胃リンパ系(その 1)-臟侧リンパ系を中心として-.消化器外科,1990,13:1957-1968.
  • 7铃木力,西卷正,神田達夫,他.胃癌術後の乳び瘘,リンバ瘘.手术,2001,55:1137-1142.
  • 8詹文华 汪建平 詹文华 主编.胃癌淋巴结清扫术[A].汪建平,詹文华,主编.胃肠外科手术学.第1版[C].北京:人民卫生出版社,2005.434-443.
  • 9Mishima Y, Hirayama R. The role of lymph node surgery in gastric cancer[J].World J Surg, 1987,11 (4):406-411.
  • 10Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric surgery in Japan and its limits of radicality[J]. World J Surg, 1987,11 (4) :418-425.

共引文献82

同被引文献35

  • 1吴钦永,杨占清,李欣,刘运喜,周鹏富,周礼,秦守荣,陈炳荣,王志.干预措施预防军事训练伤的效果[J].实用医药杂志,1999,0(1):5-5. 被引量:6
  • 2王亮,何裕隆,蔡世荣,张常华,詹文华,吴晖,彭建军.关于进展期胃癌根治术淋巴结清扫范围的荟萃分析[J].消化肿瘤杂志(电子版),2009,1(1):33-41. 被引量:9
  • 3刘莉,成伟栋,范丽琼.广州地区武警官兵军事训练伤调查分析[J].武警医学,2005,16(3):230-232. 被引量:13
  • 4Sano T,Sasako M,Yamamoto S, et al. Gastric cancer sur- gery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group study 9501 [ J ]. J Clin Oncol, 2004, 22: 2767 -2773.
  • 5Kuniaki C, Shimada H, Yamaoka H, Wakasugi J, Taka- hashi M, Akiyama H, etal. Significance of para-aorticlymph node dissection for advancedgastric cancer [ J ]. Hepatogastroenterology, 1999,46:2635-2642.
  • 6Maeta M, Yamashiro H, Saito H, et al. A prospective pilot study of extened ( D3 ) and superextended para-aortic lymphadenectomy (IM) in patients with 33 or T4 gastric cancer managed by total gastrectomy [ J ]. Surgery, 1999, 125 (3) :325-331.
  • 7Koizumi W, Akiya T, Sato A, et al. Phase I1 study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer: the Tokyo Co- operative Oncology Group study [ J ]. Cancer chemother pharmacol,2010,65 (6) : 1093-1099.
  • 8Boku N. Chemotherapy for metastatic disease:review from JCOG trial [ J ]. International Journal of Clinical Oncology, 2008,13 (3) :196.
  • 9季加孚.胃癌NCCN临床实践指南2009版解读[J].中华胃肠外科杂志,2009,12(2):107-109. 被引量:34
  • 10窦德志.军体训练中常见运动损伤的原因及预防措施[J].武警学院学报,2009,25(5):60-62. 被引量:5

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部